FENG Hao

Executive

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 4 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (5 ops.)

€5.6M

Latest filing published 03 Jul 2026 for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares, €2.6M.

Filing timeline

BuySale

FENG Hao

Insider track record

Disclosed buys

Disclosed sells

Signal history

FENG Hao: trading record in brief

All filings by FENG Hao on record concern Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares. Over a trading history stretching from 24 June 2026 to 30 June 2026, the count stands at 5 filings.

On the market, this insider has only sold: 5 sales, €5.6M in total.

The newest entry dates from 3 July 2026: an open-market sale of €2.6M, in Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from HKEX disclosures alone and does not predict where the share price will go.